Impact of pre-therapeutic fasting plasma glucose on survival outcomes in advanced non-small cell lung cancer patients
Abnormal FPG levels are independent risk factors for the long-term prognosis of advanced NSCLC. Further prospective multicenter studies are needed to confirm these associations and clarify whether glycemic assessment and management influence survival outcomes.
Authors
- Feiwen Liu (ORCID: https://orcid.org/0000-0001-5787-2895)
- Xiunan Wang (ORCID: https://orcid.org/0000-0003-4070-4101)
- Fang Wang (ORCID: https://orcid.org/0000-0001-7731-0283)
- Min Luo (ORCID: https://orcid.org/0000-0002-1506-0474)
- Ting Liang
Institutions
- Guangxi Medical University (CN)
- The People's Hospital of Guangxi Zhuang Autonomous Region (CN)
- Riverside Hospital of Guangxi Zhuang Autonomous Region (CN)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2026-01-09
- DOI
- https://doi.org/10.3389/fendo.2025.1630503
- Primary Topic
- Metabolism, Diabetes, and Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Guangxi Medical University